Codice QR

Evaluation of Efficacy and Safety of Bevacizumab Combined with Chemotherapy 
for Chinese Patients with Advanced Non-small Cell Lung Cancer

Background and objective The current study reported the result of bevacizumab treatment administered to 25 Chinese patients with advanced non-small cell lung cancer (NSCLC) who were treated at the Peking Union Medical College Hospital as a part of the SAiL (MO19390) trial. This trial is an open, int...

Descrizione completa

Salvato in:
Autori principali: Xiao ZHAO, Mengzhao WANG, Li ZHANG, Longyun LI, Wei ZHONG
Natura: Artigo
Lingua:Chinês
Pubblicazione: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2012-01-01
Serie:Chinese Journal of Lung Cancer
Soggetti:
Lung neoplasms
Bevacizumab
Adverse effect
Therapy
Accesso online:http://dx.doi.org/10.3779/j.issn.1009-3419.2012.01.02
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi